Pcn187 Budget Impact of Sequential Treatment With Afatinib Followed by Osimertinib Versus First-Line Osimertinib in Non-Small-Cell Lung Cancer Patients With Common Egfr Mutations in the Netherlands
Abstract:Resource use estimates were derived from the literature and analysis of national hospital episode statistics. Diagnosis-related group costs were used (V 2018), supplemented with cost data from Irish tertiary hospitals and the literature. A full incremental analysis was conducted, with incremental cost per quality adjusted life year (QALY) as the outcome. Probabilistic and deterministic sensitivity analyses were conducted. Results: Ipilimumab was excluded due to extended dominance, and nivolumab was dominant of… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.